NSPX

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 10/10/2017
Contact Info
  • 31200 Via Colinas
  • Suite 200
  • Westlake Village, CA 91362

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001421204
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2003
Employees 4 a/o Dec 31, 2016
Company Officers/Contacts
Christopher Lowe CEO, President
Ronald Shazer Chief Med. Officer, Senior VP
Company Directors
Peter E. Grebow Chairman
Richard E. Buller
Christopher Lowe
John Montgomery
Scott V. Ogilvie
Claire M. Thom
Service Providers
Accounting/Auditing Firm
Liggett & Webb, P.A.
432 Park Avenue South, 10 Floor
New York, NY, 10016
United States
 
Securities Counsel
Silvestre Law Group, P.C.
31200 Via Colinas
Suite 200
Westlake Village, CA, 91362
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=GenSpera, Inc. until 8-2016
NSPX Security Details
Share Structure
Market Value1 $787,013 a/o Oct 17, 2017
Authorized Shares 150,000,000 a/o Sep 30, 2016
Outstanding Shares 8,744,589 a/o Aug 05, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Shareholders
Shareholders of Record 133 a/o Apr 17, 2017
Short Selling Data
Short Interest 2,199 (98.11%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security